Nishank Jain, MBBS, MPH

Nishank Jain practices at Central Little Rock Dialysis in Little Rock, Arkansas.

Nishank Jain's NPI, 1497954515, was assigned on July 18, 2007. Nishank Jain holds Arkansas license E9182.

Nishank Jain's primary practice is Central Little Rock Dialysis, at 6115 Baseline Rd, Little Rock, AR 72209 in Pulaski County. The practice phone is (501) 664-6754.

Nishank Jain's primary practice is Central Little Rock Dialysis in Little Rock, Arkansas. Nishank Jain is also affiliated with UAMS Medical Center. The medical group on file is Nephrology Associates, PA. Dmand AI also links Nishank Jain to 4 more hospitals, 3 medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nishank Jain practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Nishank Jain's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Nishank Jain's licenses on file in 2 states: Arkansas and Texas.

CMS data shows 361 Medicare services from Nishank Jain across 8 procedure codes in 2024, for 237 Medicare patients. Medicare paid $32,099 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Nishank Jain in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nishank Jain's median patient age at 67, with 53% women.

In 2024, Nishank Jain wrote 880 Medicare Part D claims for 151 patients. 91% of them were for generic drugs. CMS names the drug for 649 of them, across 26 drugs with 11 or more claims each, at $28,316 in total drug cost. In 2023, CMS named 481 claims across 21 drugs.

Nishank Jain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Nishank Jain, published from 2011 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Renal Insufficiency, Chronic, Kidney Failure, Chronic and Platelet Aggregation Inhibitors. Nishank Jain has published most often in Am J Cardiol. Nishank Jain's most frequent co-authors are Jawahar L. Mehta, MD, John M. Arthur, MD and Robert Franklin Reilly, MD.

CMS Open Payments shows 2 general payments to Nishank Jain from 2 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $22.